British Journal of Cancer · 2007 · 64 citations · 39 references
MedicineObstetricsPreventive MedicineReproductive HealthReproductive MedicineWomen's HealthCervical InfectionCervical Intraepithelial NeoplasiaCervical LesionsCervical PathologyHuman Papillomavirus InfectionSexually Transmitted InfectionsAge-adjusted PrevalenceHigh-risk Population PrevalenceHpv EpidemiologyHpv ScreeningHuman Papillomavirus EpidemiologyHuman Papillomavirus ScreeningHuman Papillomavirus StatusSocio-demographic Inequalities
The world age-standardised prevalence of high-risk HPV (hrHPV) infection among 5038 UK women aged 20-59 years, with a low-grade smear during 1999-2002, assessed for eligibility for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) was 34.2%. High-risk HPV prevalence decreased with increasing age, from 61% at ages 20-24 years to 14-15% in those over 50 years. The age-standardised prevalence was 15.1, 30.7 and 52.7%, respectively, in women with a current normal, borderline nuclear abnormalities (BNA) and mild smear. In overall multivariate analyses, tertiary education, previous pregnancy and childbirth were associated with reduced hrHPV infection risk. Risk of infection was increased in non-white women, women not married/cohabiting, hormonal contraceptives users and current smokers. In stratified analyses, current smear status and age remained associated with hrHPV infection. Data of this type are relevant to the debate on human papillomavirus (HPV) testing in screening and development of HPV vaccination programmes.
39
Choice Reviews Online · 1990 · 35.7K citations
Lawrence L. Kupper, David W. Hosmer, Stanley Lemeshow · Journal of the American Statistical Association · 1990 · 7.7K citations
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
Robert Bierman, Leah Beardsley, Chee‐Jen Chang et al. · New England Journal of Medicine · 1998 · 2.3K citations · Full text